The results from this study suggested that ALA treatment may preserve soleus muscle mass, alleviate muscle atrophy by suppressing the TNF‐α/JNK pathway, and ameliorate the PI3K/AKT pathway in HFD/STZ‐induced type 2 diabetic rats. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.